Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 302,393,216
  • Shares Outstanding, K 2,112,422
  • Annual Sales, $ 51,722 M
  • Annual Income, $ 11,941 M
  • EBIT $ 17,558 M
  • EBITDA $ 23,672 M
  • 60-Month Beta 0.51
  • Price/Sales 5.01
  • Price/Cash Flow 13.66
  • Price/Book 6.90

Options Overview Details

View History
  • Implied Volatility 21.83% (-0.14%)
  • Historical Volatility 17.25%
  • IV Percentile 61%
  • IV Rank 16.57%
  • IV High 43.36% on 04/08/25
  • IV Low 17.55% on 11/06/25
  • Expected Move (DTE 35) 6.72 (4.69%)
  • Put/Call Vol Ratio 1.62
  • Today's Volume 299
  • Volume Avg (30-Day) 1,258
  • Put/Call OI Ratio 1.72
  • Today's Open Interest 75,685
  • Open Int (30-Day) 72,570
  • Expected Range 136.45 to 149.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.97
  • Number of Estimates 3
  • High Estimate 2.01
  • Low Estimate 1.91
  • Prior Year 1.98
  • Growth Rate Est. (year over year) -0.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
134.82 +6.13%
on 12/19/25
146.35 -2.23%
on 01/14/26
+8.06 (+5.97%)
since 12/16/25
3-Month
121.57 +17.70%
on 10/29/25
146.35 -2.23%
on 01/14/26
+12.32 (+9.42%)
since 10/16/25
52-Week
97.45 +46.83%
on 01/17/25
146.35 -2.23%
on 01/14/26
+45.23 (+46.22%)
since 01/16/25

Most Recent Stories

More News
Looking to ‘Sell America’ Amid Fed Drama? Here’s 1 ETF to Buy.

'Sell America' fear is rising again, and this non-U.S. ETF could be a wise buy to stay diversified and invested globally while U.S. policy risks swirl.

BLK : 1,174.08 (+1.51%)
BABA : 164.49 (-3.77%)
DXY00 : 99.384 (+0.06%)
SIH26 : 87.700 (-5.03%)
GCG26 : 4,569.9 (-1.16%)
NVS : 143.18 (+0.02%)
RHHBY : 54.0800 (-0.07%)
HSBC : 82.42 (-0.49%)
TSM : 344.14 (+0.73%)
ASML : 1,349.33 (+1.33%)
$DXY : 99.38 (+0.06%)
AZN : 93.87 (-0.13%)
Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

Salesforce (NYSE: CRM) , the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS) , a leading global innovative medicines company, has selected Salesforce’s...

NVS : 143.18 (+0.02%)
CRM : 228.68 (-2.08%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) on Monday rose by +1.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose by +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose by +1.82%. December E-mini S&P...

MSTR : 170.50 (-0.24%)
CADE : 44.47 (+0.16%)
AAPL : 256.76 (-0.56%)
RNA : 72.54 (-0.08%)
HBAN : 17.98 (+0.17%)
NVS : 143.18 (+0.02%)
$IUXX : 25,460.54 (-0.34%)
COIN : 238.54 (-0.31%)
ZNH26 : 111-270 (-0.33%)
TSLA : 437.75 (-0.19%)
ESH26 : 6,969.50 (-0.18%)
QCOM : 160.17 (-0.76%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. December E-mini S&P futures (ESZ25 )...

CADE : 44.47 (+0.16%)
RNA : 72.54 (-0.08%)
HBAN : 17.98 (+0.17%)
NVS : 143.18 (+0.02%)
$IUXX : 25,460.54 (-0.34%)
COIN : 238.54 (-0.31%)
ZNH26 : 111-270 (-0.33%)
TSLA : 437.75 (-0.19%)
ESH26 : 6,969.50 (-0.18%)
QCOM : 160.17 (-0.76%)
AWK : 132.98 (-0.28%)
KDP : 27.37 (-1.90%)
Stocks Rally on US-China Preliminary Trade Agreement

The S&P 500 Index ($SPX ) (SPY ) is up +0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.32%. December E-mini S&P futures (ESZ25 )...

MSTR : 170.50 (-0.24%)
CADE : 44.47 (+0.16%)
RNA : 72.54 (-0.08%)
HBAN : 17.98 (+0.17%)
NVS : 143.18 (+0.02%)
$IUXX : 25,460.54 (-0.34%)
COIN : 238.54 (-0.31%)
ZNH26 : 111-270 (-0.33%)
TSLA : 437.75 (-0.19%)
ESH26 : 6,969.50 (-0.18%)
KDP : 27.37 (-1.90%)
^ETCUSD : 12.99520 (-1.28%)
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END

BCAX : 16.81 (+0.72%)
OTLC : 0.0716 (+2.58%)
IOBT : 0.5080 (-1.55%)
NVS : 143.18 (+0.02%)
PFE : 25.64 (-0.97%)
BoC Announcement Due Next Week

Monday U.S. Economic Lookahead Durable-goods orders (Sept.) Featured Earnings ...

GOOG : 330.34 (-0.85%)
META : 622.60 (+0.29%)
AAPL : 256.76 (-0.56%)
CVX : 166.63 (+0.28%)
WELL : 189.43 (+0.66%)
NVS : 143.18 (+0.02%)
ABBV : 215.50 (+0.22%)
UNH : 334.02 (-1.46%)
MSFT : 459.70 (+0.67%)
WM : 220.10 (+0.11%)
V : 327.84 (+0.03%)
XOM : 129.55 (+0.33%)
BoC Announcement Due Next Week

Monday U.S. Economic Lookahead Durable-goods orders (Sept.) Featured Earnings ...

GOOG : 330.34 (-0.85%)
META : 622.60 (+0.29%)
AAPL : 256.76 (-0.56%)
CVX : 166.63 (+0.28%)
WELL : 189.43 (+0.66%)
NVS : 143.18 (+0.02%)
ABBV : 215.50 (+0.22%)
UNH : 334.02 (-1.46%)
MSFT : 459.70 (+0.67%)
WM : 220.10 (+0.11%)
V : 327.84 (+0.03%)
XOM : 129.55 (+0.33%)
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novartis AG, with a price target of CHF95.00. The company’s shares opened today at CHF106.36.Elevate Your Investing Strategy:...

NVS : 143.18 (+0.02%)
Should You Buy Novartis Stock Before October 28?

Novartis is gaining traction this year, but can the trend continue?

GLUE : 24.09 (+0.04%)
SDZNY : 77.2901 (+2.15%)
NVS : 143.18 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 147.54
2nd Resistance Point 146.30
1st Resistance Point 144.73
Last Price 143.18
1st Support Level 141.92
2nd Support Level 140.68
3rd Support Level 139.11

See More

52-Week High 146.35
Last Price 143.18
Fibonacci 61.8% 127.67
Fibonacci 50% 121.90
Fibonacci 38.2% 116.13
52-Week Low 97.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar